DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 49 filers reported holding DEXCOM INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $451,600 | -27.8% | 200,000 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $625,636 | +10.6% | 200,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $565,764 | +2.6% | 200,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $551,472 | +38.6% | 200,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $398,000 | +7.6% | 200,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $370,000 | -40.6% | 200,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $623,000 | -5.5% | 200,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $659,000 | -1.1% | 200,000 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $666,000 | +28.1% | 200,000 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $520,000 | +17.4% | 200,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $443,000 | -1.1% | 200,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $448,000 | -12.0% | 200,000 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $509,000 | +3.0% | 200,000 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $494,000 | -81.1% | 200,000 | -86.7% | 0.00% | -88.9% |
Q1 2020 | $2,607,000 | -70.5% | 1,500,000 | -75.0% | 0.01% | -60.9% |
Q4 2019 | $8,829,000 | – | 6,000,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
JPMORGAN CHASE & CO | 7,065,000 | $13,564,800 | 0.00% |
FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |